FDA Says Allergan Inc.'s Botox Must Carry Strong Warning on Risks

Bookmark and Share

WASHINGTON, April 30 (Reuters) - Allergan Inc’s wrinkle-smoother Botox and rival injections must carry a strong warning about potentially deadly complications if the product spreads in the body, U.S. health officials said on Thursday.

MORE ON THIS TOPIC